← SynDRA
CI-976
SynDRA canonical compound SYN1958692 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | ACAT1 | CES1 | SOAT1 |
|---|
| Mechanism of action | ACAT inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- CI 976
- 2,2-Dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide
- PD 128042
- BRN 5831010
- CHEMBL22373
- UNII-8653IQ20EA
- 8653IQ20EA
- Dodecanamide,2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)-
- Dodecanamide, 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)-
- 2,2-Dimethyl-dodecanoic acid (2,4,6-trimethoxy-phenyl)-amide
- C23H39NO4
- ACMC-1CUXF
- AC1L3UE4
- SCHEMBL691688
- CTK4A8660
- CHEBI:95040
- DTXSID00150690
- MolPort-002-018-232
- HMS3268D10
- HMS3262L19
- ZINC8022586
- Tox21_500859
- BN0150
- BDBM50005944
- AKOS022180044
- LP00859
- CCG-222163
Look up CI-976 in the interactive SynDRA portal →